 |
|
|
| |
Responsiveness of Controlled Attenuation Parameter and Its Correlation With Magnetic Resonance
Imaging-Proton Density Fat Fraction in a Multicenter Clinical Trial of Subjects With Nonalcoholic Steatohepatitis
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Mazen Noureddin,1 Zeid Kayali,2 Stephen A. Harrison,3 Peter Ruane,4 Norman Gitlin,5 Eric J. Lawitz,6 Michael Bennett,7 Raj Vuppalanchi,8 Bradley L. Freilich,9
Eliza Harting,10 Bryan McColgan,10 Robert P. Myers,10 Michael S. Middleton,11 Claude B. Sirlin,11 Michael Charlton,12 Michelle Lai,13 Parvez Mantry,12 Rohit Loomba11
1Cedars-Sinai Medical Center, Los Angeles, California, USA; 2The Liver Institute at Methodist Dallas, Texas, USA; 3Pinnacle Clinical Research, San Antonio, Texas, USA; 4Ruane Medical & Liver Health Institute, Los Angeles, California, USA; 5Atlanta Gastroenterology Associates, Atlanta, Georgia, USA; 6Texas Liver Institute and The University of Texas Health Science Center at San Antonio, Texas, USA; 7Medical Research Associates Group, San Diego, California, USA;
8Indiana University School of Medicine, Indianapolis, Indiana, USA; 9Kansas City Gastroenterology & Hepatology Physicians Group, Kansas City, Missouri, USA; 10Gilead Sciences, Inc., Foster City, California, USA; 11UC San Diego, California, USA; 12The University of Chicago, Chicago, Illinois, USA; 13Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
References
1. Chan WK, et al. J Gastroenterol Hepatol 2014;29:1470-6; 2. Middleton MS, et al. EASL 2017, abstr 483; 3. Loomba R, et al. AASLD 2017, abstr LB-9; 4. Loomba R, et al. AASLD 2017, abstr 2169;
5. Patel J, et al. Ther Adv Gastroenterol 2016;9:692-701; 6. Mantel N, et al. J Natl Cancer Inst 1959;22:719-48.
|
| |
|
|
|
|
|
